Global Meningitis B Vaccine Market Research Report 2023

Meningitis B Vaccine Market

Japanese meningitis vaccine is a vaccine used to prevent Japanese encephalitis, and vaccination against Japanese encephalitis is an effective measure to prevent Japanese encephalitis.

Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Meningitis B Vaccine market research.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Meningitis B Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

Scope of Meningitis B Vaccine Market Report

1.1 Product Overview and Scope of Meningitis B Vaccine

1.2 Meningitis B Vaccine Segment by Type

1.2.1 Global Meningitis B Vaccine Market Value Comparison by Type (2023-2029)

1.2.2 MenACWY (Conjugate) Vaccine

1.2.3 MenB (Recombinant Protein) Vaccine

1.3 Meningitis B Vaccine Segment by Application

1.3.1 Global Meningitis B Vaccine Market Value by Application: (2023-2029)

1.3.2 Hospital

1.3.3 Clinic

1.4 Global Meningitis B Vaccine Market Size Estimates and Forecasts

1.4.1 Global Meningitis B Vaccine Revenue 2018-2029

1.4.2 Global Meningitis B Vaccine Sales 2018-2029

1.4.3 Global Meningitis B Vaccine Market Average Price (2018-2029)

1.5 Assumptions and Limitations

2.1 Global Meningitis B Vaccine Sales Market Share by Manufacturers (2018-2023)

2.2 Global Meningitis B Vaccine Revenue Market Share by Manufacturers (2018-2023)

2.3 Global Meningitis B Vaccine Average Price by Manufacturers (2018-2023)

2.4 Global Meningitis B Vaccine Industry Ranking 2021 VS 2022 VS 2023

2.5 Global Key Manufacturers of Meningitis B Vaccine, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Meningitis B Vaccine, Product Type & Application

2.7 Meningitis B Vaccine Market Competitive Situation and Trends

2.7.1 Meningitis B Vaccine Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Meningitis B Vaccine Players Market Share by Revenue

2.7.3 Global Meningitis B Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3.1 Global Meningitis B Vaccine Market Size by Region: 2018 Versus 2022 Versus 2029

3.2 Global Meningitis B Vaccine Global Meningitis B Vaccine Sales by Region: 2018-2029

3.2.1 Global Meningitis B Vaccine Sales by Region: 2018-2023

3.2.2 Global Meningitis B Vaccine Sales by Region: 2024-2029

3.3 Global Meningitis B Vaccine Global Meningitis B Vaccine Revenue by Region: 2018-2029

3.3.1 Global Meningitis B Vaccine Revenue by Region: 2018-2023

3.3.2 Global Meningitis B Vaccine Revenue by Region: 2024-2029

3.4 North America Meningitis B Vaccine Market Facts & Figures by Country

3.4.1 North America Meningitis B Vaccine Market Size by Country: 2018 VS 2022 VS 2029

3.4.2 North America Meningitis B Vaccine Sales by Country (2018-2029)

3.4.3 North America Meningitis B Vaccine Revenue by Country (2018-2029)

3.4.4 United States

3.4.5 Canada

3.5 Europe Meningitis B Vaccine Market Facts & Figures by Country

3.5.1 Europe Meningitis B Vaccine Market Size by Country: 2018 VS 2022 VS 2029

3.5.2 Europe Meningitis B Vaccine Sales by Country (2018-2029)

3.5.3 Europe Meningitis B Vaccine Revenue by Country (2018-2029)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Meningitis B Vaccine Market Facts & Figures by Country

3.6.1 Asia Pacific Meningitis B Vaccine Market Size by Country: 2018 VS 2022 VS 2029

3.6.2 Asia Pacific Meningitis B Vaccine Sales by Country (2018-2029)

3.6.3 Asia Pacific Meningitis B Vaccine Revenue by Country (2018-2029)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Meningitis B Vaccine Market Facts & Figures by Country

3.7.1 Latin America Meningitis B Vaccine Market Size by Country: 2018 VS 2022 VS 2029

3.7.2 Latin America Meningitis B Vaccine Sales by Country (2018-2029)

3.7.3 Latin America Meningitis B Vaccine Revenue by Country (2018-2029)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Meningitis B Vaccine Market Facts & Figures by Country

3.8.1 Middle East and Africa Meningitis B Vaccine Market Size by Country: 2018 VS 2022 VS 2029

3.8.2 Middle East and Africa Meningitis B Vaccine Sales by Country (2018-2029)

3.8.3 Middle East and Africa Meningitis B Vaccine Revenue by Country (2018-2029)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4.1 Global Meningitis B Vaccine Sales by Type (2018-2029)

4.1.1 Global Meningitis B Vaccine Sales by Type (2018-2023)

4.1.2 Global Meningitis B Vaccine Sales by Type (2024-2029)

4.1.3 Global Meningitis B Vaccine Sales Market Share by Type (2018-2029)

4.2 Global Meningitis B Vaccine Revenue by Type (2018-2029)

4.2.1 Global Meningitis B Vaccine Revenue by Type (2018-2023)

4.2.2 Global Meningitis B Vaccine Revenue by Type (2024-2029)

4.2.3 Global Meningitis B Vaccine Revenue Market Share by Type (2018-2029)

4.3 Global Meningitis B Vaccine Price by Type (2018-2029)

5.1 Global Meningitis B Vaccine Sales by Application (2018-2029)

5.1.1 Global Meningitis B Vaccine Sales by Application (2018-2023)

5.1.2 Global Meningitis B Vaccine Sales by Application (2024-2029)

5.1.3 Global Meningitis B Vaccine Sales Market Share by Application (2018-2029)

5.2 Global Meningitis B Vaccine Revenue by Application (2018-2029)

5.2.1 Global Meningitis B Vaccine Revenue by Application (2018-2023)

5.2.2 Global Meningitis B Vaccine Revenue by Application (2024-2029)

5.2.3 Global Meningitis B Vaccine Revenue Market Share by Application (2018-2029)

5.3 Global Meningitis B Vaccine Price by Application (2018-2029)

6.1 GlaxoSmithKline

6.1.1 GlaxoSmithKline Corporation Information

6.1.2 GlaxoSmithKline Description and Business Overview

6.1.3 GlaxoSmithKline Meningitis B Vaccine Sales, Revenue and Gross Margin (2018-2023)

6.1.4 GlaxoSmithKline Meningitis B Vaccine Product Portfolio

6.1.5 GlaxoSmithKline Recent Developments/Updates

6.2 Novartis

6.2.1 Novartis Corporation Information

6.2.2 Novartis Description and Business Overview

6.2.3 Novartis Meningitis B Vaccine Sales, Revenue and Gross Margin (2018-2023)

6.2.4 Novartis Meningitis B Vaccine Product Portfolio

6.2.5 Novartis Recent Developments/Updates

6.3 BEXSERO

6.3.1 BEXSERO Corporation Information

6.3.2 BEXSERO Description and Business Overview

6.3.3 BEXSERO Meningitis B Vaccine Sales, Revenue and Gross Margin (2018-2023)

6.3.4 BEXSERO Meningitis B Vaccine Product Portfolio

6.3.5 BEXSERO Recent Developments/Updates

6.4 TRUMENBA

6.4.1 TRUMENBA Corporation Information

6.4.2 TRUMENBA Description and Business Overview

6.4.3 TRUMENBA Meningitis B Vaccine Sales, Revenue and Gross Margin (2018-2023)

6.4.4 TRUMENBA Meningitis B Vaccine Product Portfolio

6.4.5 TRUMENBA Recent Developments/Updates

6.5 Pfizer

6.5.1 Pfizer Corporation Information

6.5.2 Pfizer Description and Business Overview

6.5.3 Pfizer Meningitis B Vaccine Sales, Revenue and Gross Margin (2018-2023)

6.5.4 Pfizer Meningitis B Vaccine Product Portfolio

6.5.5 Pfizer Recent Developments/Updates

6.6 Sanofi Pasteur Inc

6.6.1 Sanofi Pasteur Inc Corporation Information

6.6.2 Sanofi Pasteur Inc Description and Business Overview

6.6.3 Sanofi Pasteur Inc Meningitis B Vaccine Sales, Revenue and Gross Margin (2018-2023)

6.6.4 Sanofi Pasteur Inc Meningitis B Vaccine Product Portfolio

6.6.5 Sanofi Pasteur Inc Recent Developments/Updates

6.7 Wyeth Pharmaceuticals, Inc.

6.6.1 Wyeth Pharmaceuticals, Inc. Corporation Information

6.6.2 Wyeth Pharmaceuticals, Inc. Description and Business Overview

6.6.3 Wyeth Pharmaceuticals, Inc. Meningitis B Vaccine Sales, Revenue and Gross Margin (2018-2023)

6.4.4 Wyeth Pharmaceuticals, Inc. Meningitis B Vaccine Product Portfolio

6.7.5 Wyeth Pharmaceuticals, Inc. Recent Developments/Updates

7.1 Meningitis B Vaccine Industry Chain Analysis

7.2 Meningitis B Vaccine Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Meningitis B Vaccine Production Mode & Process

7.4 Meningitis B Vaccine Sales and Marketing

7.4.1 Meningitis B Vaccine Sales Channels

7.4.2 Meningitis B Vaccine Distributors

7.5 Meningitis B Vaccine Customers

8.1 Meningitis B Vaccine Industry Trends

8.2 Meningitis B Vaccine Market Drivers

8.3 Meningitis B Vaccine Market Challenges

8.4 Meningitis B Vaccine Market Restraints

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

List of Tables

    Table 1. Global Meningitis B Vaccine Market Value Comparison by Type (2023-2029) & (US$ Million)

    Table 2. Global Meningitis B Vaccine Market Value Comparison by Application (2023-2029) & (US$ Million)

    Table 3. Global Meningitis B Vaccine Market Competitive Situation by Manufacturers in 2022

    Table 4. Global Meningitis B Vaccine Sales (K Units) of Key Manufacturers (2018-2023)

    Table 5. Global Meningitis B Vaccine Sales Market Share by Manufacturers (2018-2023)

    Table 6. Global Meningitis B Vaccine Revenue (US$ Million) by Manufacturers (2018-2023)

    Table 7. Global Meningitis B Vaccine Revenue Share by Manufacturers (2018-2023)

    Table 8. Global Market Meningitis B Vaccine Average Price (US$/Unit) of Key Manufacturers (2018-2023)

    Table 9. Global Key Players of Meningitis B Vaccine, Industry Ranking, 2021 VS 2022 VS 2023

    Table 10. Global Key Manufacturers of Meningitis B Vaccine, Manufacturing Sites & Headquarters

    Table 11. Global Key Manufacturers of Meningitis B Vaccine, Product Type & Application

    Table 12. Global Key Manufacturers of Meningitis B Vaccine, Date of Enter into This Industry

    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

    Table 14. Global Meningitis B Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Meningitis B Vaccine as of 2022)

    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

    Table 16. Global Meningitis B Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 17. Global Meningitis B Vaccine Sales by Region (2018-2023) & (K Units)

    Table 18. Global Meningitis B Vaccine Sales Market Share by Region (2018-2023)

    Table 19. Global Meningitis B Vaccine Sales by Region (2024-2029) & (K Units)

    Table 20. Global Meningitis B Vaccine Sales Market Share by Region (2024-2029)

    Table 21. Global Meningitis B Vaccine Revenue by Region (2018-2023) & (US$ Million)

    Table 22. Global Meningitis B Vaccine Revenue Market Share by Region (2018-2023)

    Table 23. Global Meningitis B Vaccine Revenue by Region (2024-2029) & (US$ Million)

    Table 24. Global Meningitis B Vaccine Revenue Market Share by Region (2024-2029)

    Table 25. North America Meningitis B Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 26. North America Meningitis B Vaccine Sales by Country (2018-2023) & (K Units)

    Table 27. North America Meningitis B Vaccine Sales by Country (2024-2029) & (K Units)

    Table 28. North America Meningitis B Vaccine Revenue by Country (2018-2023) & (US$ Million)

    Table 29. North America Meningitis B Vaccine Revenue by Country (2024-2029) & (US$ Million)

    Table 30. Europe Meningitis B Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 31. Europe Meningitis B Vaccine Sales by Country (2018-2023) & (K Units)

    Table 32. Europe Meningitis B Vaccine Sales by Country (2024-2029) & (K Units)

    Table 33. Europe Meningitis B Vaccine Revenue by Country (2018-2023) & (US$ Million)

    Table 34. Europe Meningitis B Vaccine Revenue by Country (2024-2029) & (US$ Million)

    Table 35. Asia Pacific Meningitis B Vaccine Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)

    Table 36. Asia Pacific Meningitis B Vaccine Sales by Region (2018-2023) & (K Units)

    Table 37. Asia Pacific Meningitis B Vaccine Sales by Region (2024-2029) & (K Units)

    Table 38. Asia Pacific Meningitis B Vaccine Revenue by Region (2018-2023) & (US$ Million)

    Table 39. Asia Pacific Meningitis B Vaccine Revenue by Region (2024-2029) & (US$ Million)

    Table 40. Latin America Meningitis B Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 41. Latin America Meningitis B Vaccine Sales by Country (2018-2023) & (K Units)

    Table 42. Latin America Meningitis B Vaccine Sales by Country (2024-2029) & (K Units)

    Table 43. Latin America Meningitis B Vaccine Revenue by Country (2018-2023) & (US$ Million)

    Table 44. Latin America Meningitis B Vaccine Revenue by Country (2024-2029) & (US$ Million)

    Table 45. Middle East & Africa Meningitis B Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 46. Middle East & Africa Meningitis B Vaccine Sales by Country (2018-2023) & (K Units)

    Table 47. Middle East & Africa Meningitis B Vaccine Sales by Country (2024-2029) & (K Units)

    Table 48. Middle East & Africa Meningitis B Vaccine Revenue by Country (2018-2023) & (US$ Million)

    Table 49. Middle East & Africa Meningitis B Vaccine Revenue by Country (2024-2029) & (US$ Million)

    Table 50. Global Meningitis B Vaccine Sales (K Units) by Type (2018-2023)

    Table 51. Global Meningitis B Vaccine Sales (K Units) by Type (2024-2029)

    Table 52. Global Meningitis B Vaccine Sales Market Share by Type (2018-2023)

    Table 53. Global Meningitis B Vaccine Sales Market Share by Type (2024-2029)

    Table 54. Global Meningitis B Vaccine Revenue (US$ Million) by Type (2018-2023)

    Table 55. Global Meningitis B Vaccine Revenue (US$ Million) by Type (2024-2029)

    Table 56. Global Meningitis B Vaccine Revenue Market Share by Type (2018-2023)

    Table 57. Global Meningitis B Vaccine Revenue Market Share by Type (2024-2029)

    Table 58. Global Meningitis B Vaccine Price (US$/Unit) by Type (2018-2023)

    Table 59. Global Meningitis B Vaccine Price (US$/Unit) by Type (2024-2029)

    Table 60. Global Meningitis B Vaccine Sales (K Units) by Application (2018-2023)

    Table 61. Global Meningitis B Vaccine Sales (K Units) by Application (2024-2029)

    Table 62. Global Meningitis B Vaccine Sales Market Share by Application (2018-2023)

    Table 63. Global Meningitis B Vaccine Sales Market Share by Application (2024-2029)

    Table 64. Global Meningitis B Vaccine Revenue (US$ Million) by Application (2018-2023)

    Table 65. Global Meningitis B Vaccine Revenue (US$ Million) by Application (2024-2029)

    Table 66. Global Meningitis B Vaccine Revenue Market Share by Application (2018-2023)

    Table 67. Global Meningitis B Vaccine Revenue Market Share by Application (2024-2029)

    Table 68. Global Meningitis B Vaccine Price (US$/Unit) by Application (2018-2023)

    Table 69. Global Meningitis B Vaccine Price (US$/Unit) by Application (2024-2029)

    Table 70. GlaxoSmithKline Corporation Information

    Table 71. GlaxoSmithKline Description and Business Overview

    Table 72. GlaxoSmithKline Meningitis B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 73. GlaxoSmithKline Meningitis B Vaccine Product

    Table 74. GlaxoSmithKline Recent Developments/Updates

    Table 75. Novartis Corporation Information

    Table 76. Novartis Description and Business Overview

    Table 77. Novartis Meningitis B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 78. Novartis Meningitis B Vaccine Product

    Table 79. Novartis Recent Developments/Updates

    Table 80. BEXSERO Corporation Information

    Table 81. BEXSERO Description and Business Overview

    Table 82. BEXSERO Meningitis B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 83. BEXSERO Meningitis B Vaccine Product

    Table 84. BEXSERO Recent Developments/Updates

    Table 85. TRUMENBA Corporation Information

    Table 86. TRUMENBA Description and Business Overview

    Table 87. TRUMENBA Meningitis B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 88. TRUMENBA Meningitis B Vaccine Product

    Table 89. TRUMENBA Recent Developments/Updates

    Table 90. Pfizer Corporation Information

    Table 91. Pfizer Description and Business Overview

    Table 92. Pfizer Meningitis B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 93. Pfizer Meningitis B Vaccine Product

    Table 94. Pfizer Recent Developments/Updates

    Table 95. Sanofi Pasteur Inc Corporation Information

    Table 96. Sanofi Pasteur Inc Description and Business Overview

    Table 97. Sanofi Pasteur Inc Meningitis B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 98. Sanofi Pasteur Inc Meningitis B Vaccine Product

    Table 99. Sanofi Pasteur Inc Recent Developments/Updates

    Table 100. Wyeth Pharmaceuticals, Inc. Corporation Information

    Table 101. Wyeth Pharmaceuticals, Inc. Description and Business Overview

    Table 102. Wyeth Pharmaceuticals, Inc. Meningitis B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 103. Wyeth Pharmaceuticals, Inc. Meningitis B Vaccine Product

    Table 104. Wyeth Pharmaceuticals, Inc. Recent Developments/Updates

    Table 105. Key Raw Materials Lists

    Table 106. Raw Materials Key Suppliers Lists

    Table 107. Meningitis B Vaccine Distributors List

    Table 108. Meningitis B Vaccine Customers List

    Table 109. Meningitis B Vaccine Market Trends

    Table 110. Meningitis B Vaccine Market Drivers

    Table 111. Meningitis B Vaccine Market Challenges

    Table 112. Meningitis B Vaccine Market Restraints

    Table 113. Research Programs/Design for This Report

    Table 114. Key Data Information from Secondary Sources

    Table 115. Key Data Information from Primary Sources

List of Figures

    Figure 1. Product Picture of Meningitis B Vaccine

    Figure 2. Global Meningitis B Vaccine Market Value Comparison by Type (2023-2029) & (US$ Million)

    Figure 3. Global Meningitis B Vaccine Market Share by Type in 2022 & 2029

    Figure 4. MenACWY (Conjugate) Vaccine Product Picture

    Figure 5. MenB (Recombinant Protein) Vaccine Product Picture

    Figure 6. Global Meningitis B Vaccine Market Value Comparison by Application (2023-2029) & (US$ Million)

    Figure 7. Global Meningitis B Vaccine Market Share by Application in 2022 & 2029

    Figure 8. Hospital

    Figure 9. Clinic

    Figure 10. Global Meningitis B Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2029

    Figure 11. Global Meningitis B Vaccine Market Size (2018-2029) & (US$ Million)

    Figure 12. Global Meningitis B Vaccine Sales (2018-2029) & (K Units)

    Figure 13. Global Meningitis B Vaccine Average Price (US$/Unit) & (2018-2029)

    Figure 14. Meningitis B Vaccine Report Years Considered

    Figure 15. Meningitis B Vaccine Sales Share by Manufacturers in 2022

    Figure 16. Global Meningitis B Vaccine Revenue Share by Manufacturers in 2022

    Figure 17. The Global 5 and 10 Largest Meningitis B Vaccine Players: Market Share by Revenue in 2022

    Figure 18. Meningitis B Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022

    Figure 19. Global Meningitis B Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Figure 20. North America Meningitis B Vaccine Sales Market Share by Country (2018-2029)

    Figure 21. North America Meningitis B Vaccine Revenue Market Share by Country (2018-2029)

    Figure 22. United States Meningitis B Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 23. Canada Meningitis B Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 24. Europe Meningitis B Vaccine Sales Market Share by Country (2018-2029)

    Figure 25. Europe Meningitis B Vaccine Revenue Market Share by Country (2018-2029)

    Figure 26. Germany Meningitis B Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 27. France Meningitis B Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 28. U.K. Meningitis B Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 29. Italy Meningitis B Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 30. Russia Meningitis B Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 31. Asia Pacific Meningitis B Vaccine Sales Market Share by Region (2018-2029)

    Figure 32. Asia Pacific Meningitis B Vaccine Revenue Market Share by Region (2018-2029)

    Figure 33. China Meningitis B Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 34. Japan Meningitis B Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 35. South Korea Meningitis B Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 36. India Meningitis B Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 37. Australia Meningitis B Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 38. China Taiwan Meningitis B Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 39. Indonesia Meningitis B Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 40. Thailand Meningitis B Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 41. Malaysia Meningitis B Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 42. Latin America Meningitis B Vaccine Sales Market Share by Country (2018-2029)

    Figure 43. Latin America Meningitis B Vaccine Revenue Market Share by Country (2018-2029)

    Figure 44. Mexico Meningitis B Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 45. Brazil Meningitis B Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 46. Argentina Meningitis B Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 47. Middle East & Africa Meningitis B Vaccine Sales Market Share by Country (2018-2029)

    Figure 48. Middle East & Africa Meningitis B Vaccine Revenue Market Share by Country (2018-2029)

    Figure 49. Turkey Meningitis B Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 50. Saudi Arabia Meningitis B Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 51. UAE Meningitis B Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 52. Global Sales Market Share of Meningitis B Vaccine by Type (2018-2029)

    Figure 53. Global Revenue Market Share of Meningitis B Vaccine by Type (2018-2029)

    Figure 54. Global Meningitis B Vaccine Price (US$/Unit) by Type (2018-2029)

    Figure 55. Global Sales Market Share of Meningitis B Vaccine by Application (2018-2029)

    Figure 56. Global Revenue Market Share of Meningitis B Vaccine by Application (2018-2029)

    Figure 57. Global Meningitis B Vaccine Price (US$/Unit) by Application (2018-2029)

    Figure 58. Meningitis B Vaccine Value Chain

    Figure 59. Meningitis B Vaccine Production Process

    Figure 60. Channels of Distribution (Direct Vs Distribution)

    Figure 61. Distributors Profiles

    Figure 62. Bottom-up and Top-down Approaches for This Report

    Figure 63. Data Triangulation

    Figure 64. Key Executives Interviewed